OpenVSafe by OpenVAERS
Search V-safe

C7S-25209-25701

3 vaccinations 2 coded responses 19 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
31-35
ZIP prefix
902 / CA
Registered
2021-08-11
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-08-10
    Dose 1 — Pfizer-BioNTech
  2. 2021-08-11
    Registered in v-safe
  3. 2021-08-11
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-08-12
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-08-15
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-08-16
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-08-17
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-08-24
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  9. 2021-08-31
    Dose 2 — Pfizer-BioNTech
  10. 2021-09-07
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-09-16
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-09-21
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-09-28
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-10-05
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-10-14
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-11-30
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  17. 2022-03-03
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  18. 2022-06-08
    Dose 3 — Pfizer-BioNTech
  19. 2022-06-21
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  20. 2022-06-22
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  21. 2022-07-01
    Survey response — day 21, dose 3
    MedDRA: Aphonia — Feeling: Good
    Free text: Loss of voice
    MedDRA releases: 2024-11 · check-in free text available
  22. 2022-09-09
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  23. 2022-12-07
    Survey response — 6 months, dose 3
    MedDRA: Respiratory syncytial virus infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: RSV
    MedDRA releases: 2024-11 · check-in free text available
  24. 2022-12-07
    Report sent to call center — 6 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  25. 2022-12-08

Vaccinations

DoseDateManufacturerCo-administered
12021-08-10Pfizer-BioNTech No
22021-08-31Pfizer-BioNTech No
32022-06-08Pfizer-BioNTech No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 12 — day 21, dose 3

2022-07-01

Symptoms: Loss of voice

Release 12 — 6 months, dose 3

2022-12-07

Symptoms: RSV

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAphonia · · ✓
SDRespiratory syncytial virus infection · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…